macular pigment analyser
france medical pty ltd -
acular 0,5% topical ophthalmic solution
allergan -
acular 0.5% col·liri solució 5 ml
acular gervasi 0.5% col·liri solució 5 ml
jetrea rtu ocriplasmin (ryp) 0.375 mg/0.3 ml solution for intravitreal injection vial
i-care pharma distributors pty ltd - ocriplasmin, quantity: 1.25 mg/ml - injection, solution - excipient ingredients: mannitol; citric acid monohydrate; sodium chloride; sodium hydroxide; hydrochloric acid; water for injections - jetrea rtu is indicated in adults for the treatment of vitreomacular traction (vmt), including when associated with macular hole of diameter less than or equal to 400 microns.
eylea
bayer israel ltd - aflibercept - solution for intravitreal injection - aflibercept 40 mg/ml - aflibercept - eylea is indicated for adults for the treatment of • neovascular (wet) age-related macular degeneration (amd)• visual impairment due to macular oedema secondary to retinal vein occlusion (branch crvo or central rvo)• visual impairment due to diabetic macular oedema (dme)• visual impairment due to myopic choroidal neovascularisation (myopic cnv).
vabysmo
roche registration gmbh - faricimab - wet macular degeneration; macular edema; diabetes complications - ophthalmologicals - vabysmo is indicated for the treatment of adult patients with:neovascular (wet) age-related macular degeneration (namd),visual impairment due to diabetic macular oedema (dme).
beovu
novartis europharm limited - brolucizumab - wet macular degeneration - ophthalmologicals - beovu is indicated in adults for the treatment of neovascular (wet) age-related macular degeneration (amd).
beovu brolucizumab (rbe) 120 mg/ml solution for injection in vial
novartis pharmaceuticals australia pty ltd - brolucizumab, quantity: 120 mg/ml - injection, solution - excipient ingredients: sodium citrate; sucrose; polysorbate 80; water for injections - beovu is indicated for the treatment of: - neovascular (wet) age-related macular degeneration (amd). - diabetic macular oedema (dme)
maqaid ophthalmic injection 40mg [reduction of macular edema complicated with diabetic macular edema] (マキュエイド眼注用40mg[糖尿病黄斑浮腫に伴う黄斑浮腫の軽減])
wakamoto pharmaceutical co., ltd - triamcinolone acetonide - injection